Dextenza drops after eye surgery to reduce post-op pain
Part of Pain clinical trials.
This trial studies whether Dextenza (a steroid pain-relief eye insert) can improve comfort after a specific type of retina surgery (pars plana vitrectomy). It looks at people getting surgery for conditions like macular hole, epiretinal membrane, or vitreomacular traction.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 or older and planning pars plana vitrectomy for a retina condition
- Your surgery is only the vitrectomy (not combined cataract/glaucoma surgery, lens change, scleral buckle, or drug-delivery implant)
- No significant active inflammation in the study eye at the screening/baseline visit
- You do not have eye pain at baseline (pain score must be 0)
- You don’t have certain eye problems (like lid turning in/out) or recent/other eye surgeries close to this study
- You can’t use certain medicines right before surgery (like NSAID eye drops, and steroid medicines within set time windows)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 4 study looks at a treatment plan around the time of planned surgery on both eyes (called RLE). It may help the researchers learn how safe and effective the approach is for improving eye outcomes after surgery.
This trial compares two ways to manage inflammation after corneal crosslinking for keratoconus: a tiny steroid insert placed in the tear duct versus standard steroid eye drops. It aims to see which option is easier and works just as well.
This study tests whether a steroid medication can help reduce swelling in the back of the eye caused by diabetic macular edema, a complication of type 2 diabetes. If you qualify, you may receive this treatment to potentially improve your vision.
This study tests combining vitrectomy (surgery to remove the membrane from the retina) with a dexamethasone implant (a tiny steroid that is placed inside the eye to reduce swelling) for people with a specific type of eye membrane and fluid buildup in the center of the retina.
This trial looks at which long-acting steroid implant works better for diabetic macular swelling that did not improve enough with past treatments. It may help patients by testing a treatment option aimed at improving vision when other eye injections have not worked well.
This study tests whether anti-inflammatory eye drops (nepafenac, an NSAID) can help reduce swelling in the macula (the sharp-vision part of the eye) after certain cornea transplant surgeries. It compares outcomes in adults having DSAEK or DMEK who can safely use the study drops.
Hear when a new Post Operative Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.